Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes

BACKGROUND/ OBJECTIVES: DRAKO (NCT02850263) was a 24-month, prospective, observational, multi-centre cohort study that enrolled patients diagnosed with diabetic macular oedema (DMO) including central involvement. The study aimed to evaluate standard of care intravitreal aflibercept (IVT-AFL) treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb, Napier, Jackie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482829/
https://www.ncbi.nlm.nih.gov/pubmed/36941402
http://dx.doi.org/10.1038/s41433-023-02409-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482829/
https://www.ncbi.nlm.nih.gov/pubmed/36941402
http://dx.doi.org/10.1038/s41433-023-02409-y

Ejemplares similares